Cargando…

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model

Peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ) agonists have anti-inflammatory and anti-neovascularization effects, but few reports have tested the combination of PPARα and PPARγ agonists. In this study, we investigated the therapeutic effects of ophthalmic solutions of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Yuji, Arima, Takeshi, Tobita, Yutaro, Uchiyama, Masaaki, Shimizu, Akira, Takahashi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404145/
https://www.ncbi.nlm.nih.gov/pubmed/32707656
http://dx.doi.org/10.3390/ijms21145093
_version_ 1783567087247032320
author Nakano, Yuji
Arima, Takeshi
Tobita, Yutaro
Uchiyama, Masaaki
Shimizu, Akira
Takahashi, Hiroshi
author_facet Nakano, Yuji
Arima, Takeshi
Tobita, Yutaro
Uchiyama, Masaaki
Shimizu, Akira
Takahashi, Hiroshi
author_sort Nakano, Yuji
collection PubMed
description Peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ) agonists have anti-inflammatory and anti-neovascularization effects, but few reports have tested the combination of PPARα and PPARγ agonists. In this study, we investigated the therapeutic effects of ophthalmic solutions of agonists of PPARα, PPARγ, and the combination in a rat corneal alkali burn model. After alkali injury, an ophthalmic solution of 0.05% fenofibrate (PPARα group), 0.1% pioglitazone (PPARγ group), 0.05% fenofibrate + 0.1% pioglitazone (PPARα+γ group), or vehicle (vehicle group) was topically instilled onto the rat’s cornea twice a day. After instillation, upregulation was seen of PPAR mRNA corresponding to each agonist group. Administration of agonists for PPARα, PPARγ, and PPARα+γ suppressed inflammatory cells, neovascularization, and fibrotic changes. In addition, the PPARγ agonist upregulated M2 macrophages, which contributed to wound healing, whereas the PPARα agonist suppressed immature blood vessels in the early phase. Administration of PPARα+γ agonists showed therapeutic effects in corneal wound healing, combining the characteristics of both PPARα and PPARγ agonists. The results indicate that the combination of PPARα and γ agonists may be a new therapeutic strategy.
format Online
Article
Text
id pubmed-7404145
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74041452020-08-11 Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model Nakano, Yuji Arima, Takeshi Tobita, Yutaro Uchiyama, Masaaki Shimizu, Akira Takahashi, Hiroshi Int J Mol Sci Article Peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ) agonists have anti-inflammatory and anti-neovascularization effects, but few reports have tested the combination of PPARα and PPARγ agonists. In this study, we investigated the therapeutic effects of ophthalmic solutions of agonists of PPARα, PPARγ, and the combination in a rat corneal alkali burn model. After alkali injury, an ophthalmic solution of 0.05% fenofibrate (PPARα group), 0.1% pioglitazone (PPARγ group), 0.05% fenofibrate + 0.1% pioglitazone (PPARα+γ group), or vehicle (vehicle group) was topically instilled onto the rat’s cornea twice a day. After instillation, upregulation was seen of PPAR mRNA corresponding to each agonist group. Administration of agonists for PPARα, PPARγ, and PPARα+γ suppressed inflammatory cells, neovascularization, and fibrotic changes. In addition, the PPARγ agonist upregulated M2 macrophages, which contributed to wound healing, whereas the PPARα agonist suppressed immature blood vessels in the early phase. Administration of PPARα+γ agonists showed therapeutic effects in corneal wound healing, combining the characteristics of both PPARα and PPARγ agonists. The results indicate that the combination of PPARα and γ agonists may be a new therapeutic strategy. MDPI 2020-07-19 /pmc/articles/PMC7404145/ /pubmed/32707656 http://dx.doi.org/10.3390/ijms21145093 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nakano, Yuji
Arima, Takeshi
Tobita, Yutaro
Uchiyama, Masaaki
Shimizu, Akira
Takahashi, Hiroshi
Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
title Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
title_full Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
title_fullStr Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
title_full_unstemmed Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
title_short Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
title_sort combination of peroxisome proliferator-activated receptor (ppar) alpha and gamma agonists prevents corneal inflammation and neovascularization in a rat alkali burn model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404145/
https://www.ncbi.nlm.nih.gov/pubmed/32707656
http://dx.doi.org/10.3390/ijms21145093
work_keys_str_mv AT nakanoyuji combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel
AT arimatakeshi combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel
AT tobitayutaro combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel
AT uchiyamamasaaki combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel
AT shimizuakira combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel
AT takahashihiroshi combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel